Psychopharmacology and psychotherapy: What's the connection?

Journal of Psychiatric Practice

Volumn 12, Issue 1, 2006, Pages 41-45

  Preskorn, Sheldon H ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b University of Montreal   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ALZHEIMER DISEASE; COMPUTER; DISEASE CLASSIFICATION; DRUG EFFICACY; HUMAN; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROTRANSMISSION; PANIC; PATHOPHYSIOLOGY; PHOBIA; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; REVIEW; SCHIZOPHRENIA; SENILE DEMENTIA; SYMPTOMATOLOGY; SYNAPSE; ARTICLE; DRUG EFFECT; LITERATURE; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

COMBINED MODALITY THERAPY; HUMANS; MENTAL DISORDERS; METAPHOR; PATIENT SELECTION; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 33646196091     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131746-200601000-00006     Document Type: Review

References (6)

1. Klein DF. False suffocation alarms, spontaneous panics, and related conditions: An integrative hypothesis. Arch Gen Psychiatry 1993;50:306-17.
2. Etkin A, Pittenger C, Polan HJ, et al. Toward a neurobiology of psychotherapy: Basic science and clinical applications. J Neuropsychiatry Clin Neurosci 2005 Spring;17:145-58.
3. Roffman JL, Marci CD, Glick DM, et al. Neuroimaging and the functional neuroanatomy of psychotherapy. Psychol Med 2005;35:1385-98.
4. Gaudiano BA. Is Symptomatic improvement in clinical trials of cognitive-behavioral therapy for psychosis clinically significant? J Psychiatr Pract 2006;12:11-23.
5. Richelson E, Pharmacology of antidepressants: Characteristics of the ideal drug. Mayo Clin Proc. 1994;69:1069-81.
6. Preskorn SH. Modern drug development and the human genome project. Series of columns published in the Journal of Psychiatric Practice between 2000 and 2002 (Available at www.preskorn.com/column4.html).